Gara Jalqabaatti › Dhukkuba Fabry
Qorannoo klinikaalii Dhukkuba Fabry Ameerikaa Keessatti hirmaatuu
Qorannoo 10 Dhukkuba Fabry f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Atlanta, GAQorannoo 6
- Arlington, VAQorannoo 6
- Minneapolis, MNQorannoo 4
- Pittsburgh, PAQorannoo 4
- Cincinnati, OHQorannoo 4
- Birmingham, ALQorannoo 4
- Chicago, ILQorannoo 3
- Salt Lake City, UTQorannoo 3
- New York City, NYQorannoo 3
- Cedar Rapids, IAQorannoo 3
Naannoon
- AlabamaQorannoo 4
- GeorgiaQorannoo 6
- IllinoisQorannoo 3
- IowaQorannoo 3
- MinnesotaQorannoo 4
- New YorkQorannoo 4
- OhioQorannoo 4
- PennsylvaniaQorannoo 5
- UtahQorannoo 3
- VirginiaQorannoo 6
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 65 · Dhiroota · Haaromfame 24-Ful-2026 · NCT06270316A Study of Patients With Fabry Disease (US Specific)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06906367A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 11 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06904261Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 1 hanga 75 · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT01581424Cardiovascular Multimodality Imaging Study
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06610019A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06328608Fabry Disease Registry & Pregnancy Sub-registry
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT00196742Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Dubartoota · Haaromfame 19-Bit-2026 · NCT06941025A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Sad-2025 · NCT06663358A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Dubartoota · Haaromfame 08-Ado-2025 · NCT04252066Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.